Clinical trials
Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Terminated | 5 |
| Completed | 4 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Princess Maxima Center for Pediatric Oncology | 3 |
| AstraZeneca | 2 |
| University College, London | 2 |
| University of Birmingham | 2 |
| AbbVie | 1 |
| Autolus Limited | 1 |
| Bellicum Pharmaceuticals | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia | 6 |
| Burkitt Lymphoma | 5 |
| Recurrence | 5 |
| Myelodysplastic Syndromes | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.